rs779101863
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000606589.1(ENSG00000272104):c.*126G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000719 in 1,529,830 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000073 ( 0 hom. )
Consequence
ENSG00000272104
ENST00000606589.1 3_prime_UTR
ENST00000606589.1 3_prime_UTR
Scores
2
Splicing: ADA: 0.004456
2
Clinical Significance
Conservation
PhyloP100: 0.945
Publications
0 publications found
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
- cerebellar atrophy with seizures and variable developmental delayInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- complex neurodevelopmental disorderInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-50367912-G-T is Benign according to our data. Variant chr3-50367912-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 461307.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ENSG00000272104 | ENST00000606589.1 | c.*126G>T | 3_prime_UTR_variant | Exon 4 of 4 | 3 | ENSP00000476225.1 | ||||
| CACNA2D2 | ENST00000424201.7 | c.2144-10C>A | intron_variant | Intron 24 of 37 | 1 | NM_006030.4 | ENSP00000390329.2 | |||
| CACNA2D2 | ENST00000423994.6 | c.2165-10C>A | intron_variant | Intron 25 of 38 | 5 | ENSP00000407393.2 | ||||
| CACNA2D2 | ENST00000266039.7 | c.2144-10C>A | intron_variant | Intron 24 of 37 | 1 | ENSP00000266039.3 | ||||
| CACNA2D2 | ENST00000360963.7 | c.1937-10C>A | intron_variant | Intron 24 of 37 | 1 | ENSP00000354228.3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151974Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000264 AC: 6AN: 227646 AF XY: 0.0000162 show subpopulations
GnomAD2 exomes
AF:
AC:
6
AN:
227646
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000726 AC: 10AN: 1377856Hom.: 0 Cov.: 28 AF XY: 0.00000581 AC XY: 4AN XY: 687984 show subpopulations
GnomAD4 exome
AF:
AC:
10
AN:
1377856
Hom.:
Cov.:
28
AF XY:
AC XY:
4
AN XY:
687984
show subpopulations
African (AFR)
AF:
AC:
0
AN:
31600
American (AMR)
AF:
AC:
7
AN:
43198
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25338
East Asian (EAS)
AF:
AC:
0
AN:
38752
South Asian (SAS)
AF:
AC:
0
AN:
83042
European-Finnish (FIN)
AF:
AC:
0
AN:
51846
Middle Eastern (MID)
AF:
AC:
0
AN:
5446
European-Non Finnish (NFE)
AF:
AC:
3
AN:
1041164
Other (OTH)
AF:
AC:
0
AN:
57470
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.535
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151974Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74244 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
151974
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74244
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41384
American (AMR)
AF:
AC:
1
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5170
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67942
Other (OTH)
AF:
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy Benign:1
Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.